 |
 |
Dr. Reddy's to release Q3 FY10 results on Jan 20, 2010
Earnings call slated for Jan 20, 6.30 PM IST / 8.00 AM EST
Hyderabad, India, January 11, 2010: Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the Third quarter ended December 31, 2009 on Wednesday, January 20, 2010 after the Board Meeting. The results will be available on the Company’s website www.drreddys.com
Summary of Events
| Event | Date and Time (IST) | Medium |
Release of financial results |
January 20, after the Board Meeting |
Email, Media, Company website, Businesswire |
Earnings Call |
January 20, 6.30 PM IST / 8:00 AM EST |
Hosted by the Company |
Webcast of Earnings Call |
January 20, 6.30 PM IST / 8.00 AM EST through January 25, 2010 |
URL available on Company’s website, www.drreddys.com |
Transcripts of the Earnings call |
Will be available on the Company’s website |
URL available on Company’s website, www.drreddys.com |
Earnings Call
Following the release, the management of the Company will host an earnings call to discuss the Company’s financial performance.
| Conference Dial-In Numbers | |
Primary Number: |
+91 22 4039 2525 |
| The numbers listed above are universally accessible from all networks and all countries. | |
| Local Access Number: | 3940 3977 6000 1221 |
| * The Local Access Number is accessible from all major carriers except BSNL/MTNL | |
| International Toll Free Number: | USA: 1 866 746 2133 UK: 0 808 101 1573 Singapore: 800 101 2045 Hong Kong: 800 964 448 |
No password/pin number is necessary to dial in to any of the other calls. As participation in the call is limited, early registration is encouraged. The operator will provide instructions on asking questions before and during the call.
Audio Webcast
The audio webcast of the earnings call will be available to all interested parties at www.drreddys.com. Please visit the web site at least fifteen minutes ahead of the scheduled start time to register and to download and install any necessary audio software. Participants in the webcast can listen to the proceedings, but will not be able to ask questions. The replay will be available 2 hours after the earnings call, through January 25, 2010. For play back dial in phone No: 022 3065 1212 and ID: 375#.
Transcript
The transcript of the earnings call will also be available on the Company's website.
About Dr Reddy’s
Established in 1984, Dr. Reddy’s Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven basic research capabilities. The company develops, manufactures and markets a wide range of pharmaceutical products in India and overseas. Dr. Reddy’s produces finished dosage forms, active pharmaceutical ingredients, diagnostic kits, critical care and biotechnology products. The basic research program of Dr. Reddy’s focuses on cancer, diabetes, bacterial infections and pain management. Website: www.drreddys.com
Contact
For further information please contact:
Investor Relations:
Kedar Upadhye at kedaru@drreddys.com /+91 40 66834297
Raghavender R at raghavenderr@drreddys.com /+91 40 66511529
Milan Kalawadia (USA) at mkalawadia@drreddys.com / +1 9082034931
